newsfilter
← Latest News
GlobeNewswire·

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2026

Company Announcement Net sales of DARZALEX® in the second quarter of 2026 totaled USD 4,207 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech,